{"name":"ABLi Therapeutics, Inc.","slug":"abli-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxOTTVjZXM5TUxFS0tnTmRLWlA1cUNRNWI3SEd2ekVjZFBNVGZvcE93Yzg4bEc4bUxFdkdzOUFsS2dpQXNfcWZVbllGTXNjbU5uTUJsZDJ6SjlhdEQxTGV5QWxKMExKWFlKVE5WUEdDVXk1Q3NEQlB5ejZVUy1rOWYtc0FWSGNrTjNpc0dHSzNDSUh3aGY3d2RBMlhhcHFKbklzY0o2OHlINEpEemNYNDNSbHlocW5BbVNDZ2JCaFlLYkdGWjFteEY5bENGVzRxT0NKazZ1SnM3WE0zTmwzVXpuUVFSWF9yZVJBeWZmODJ2cC1XMFcxNnlfTFZOYTVGVnVCdF9JdTkzLWdSQUZGdUFOcEhSOVZyREp0TnRLaV9pUklpcnNPRTVjTG96ZDJoZ1lVZnpBNDMxVm82eU1h?oc=5","date":"2025-05-21","type":"trial","source":"GlobeNewswire","summary":"ABLi Therapeutics Announces Details of the End of Phase 2 - GlobeNewswire","headline":"ABLi Therapeutics Announces Details of the End of Phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPVWphc3RERTVXemFqZ1MzQzUzVTBVWlNQVG1aZDlrNjRtdFFLUXo1Q3hwYlVranc3V052dXF0SEZja2ZWbEx2OHRpYV8wSUJkVTEweFlfbE4teHpMNXZhMG1faGJ6ZzJzYTlyM0J4Sm0zNW1ldW84S2s4TkM2WGVmMnRUaUlEdTVESzJ1QUJvZmpRa2hTdjhKOHRKNWpTdHZvUXNoNUo1Z0dlTmdmLTB5a2xB?oc=5","date":"2025-05-13","type":"pipeline","source":"Fierce Biotech","summary":"J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus - Fierce Biotech","headline":"J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONHF0MzhvczZRdFNUcUdKNnBvV1hJQTk2SEx3UkNfY2xreTdXVEZjM1VkOXhQa25PYm1IZWV0YXYzWUVkNktoQU9JT0dSMkZ2YmxlTlUyb2x4SlF6cTJRNjFSTF9ob1lsa2g4Nm5wMi1HdjRWazRFX2p6dDVwanNyaXprQ3haMDNTeW85aEdCQ1BKTkhuRHd0aEJtMFJzNE01b0xiRmNsaFVkaS1mWXBKS3Bzdy1RMmlhOU5VNER3SFNqUkU?oc=5","date":"2025-05-12","type":"pipeline","source":"Fierce Biotech","summary":"Former Inhibikase leader launches new biotech for midstage Parkinson's asset - Fierce Biotech","headline":"Former Inhibikase leader launches new biotech for midstage Parkinson's asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxNZGFaenI4VGFTMFR1THJaOXg1d1FzYnlfd1NyU1BUb2VudEVyamZKR1Z2RDc2R19LS1Vtay1Sb0xhd05ERlBoZHRRRWFaMVg3T0lSdXBWZWJPbGZPRm5FeDVacEtLTmdWNnE5WDFGY003OUREcmpSRVZoT2pacmNhVU5CNGszbEt0cEJHLWtPMEgySDU4TkRPM0plZjZmMllFT01FYkJOSnVERVZCUURQSm9rTjVDSkF2cklxMFVldGFMUFRGYkVfSTBhOXZsRVlrb2lmYUR2T01ZMGZQOU9ISGtfNHF5Q1VhQVRtblZkZ0Y5MWEzWXcxeXdjQUlSVEh3bW5JUWpYZnhneWZtMllIM1ExX195eGlKdDdmZjdoWFFLeGZEZ2JPOVFHaWs2QXlQR0ZsZTlR?oc=5","date":"2025-05-12","type":"pipeline","source":"GlobeNewswire","summary":"ABLi Therapeutics Launches with a Focus on Developing - GlobeNewswire","headline":"ABLi Therapeutics Launches with a Focus on Developing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}